TGF-β and FRF-21: association with IHD in patients with type 2 diabetes and obesity

TGF-β and FRF-21: association with IHD in patients with type 2 diabetes and obesity

Backgraund: Obesity and type 2 diabetes mellitus (T2DM) are associated with with an increased risk of cardiovascular disease (CVD) and coronary artery disease (CAD), in particular. Obesity lead to several fibrotic processes, including activation of transforming growth factor β (TGF-β). Recent dat...

Full description

Bibliographic Details
Main Authors:	Teona A. Shvangiradze, Irina Z. Bondarenko, Ekaterina A. Troshina, Larisa V. Nikankina, Svetlana S. Kukharenko, Marina V. Shestakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2017-11-01
Series:	Ожирение и метаболизм
Subjects:	ожирение сахарный диабет сердечно-сосудистые заболевания трансформирующий фактор роста β фактор роста фибробластов 21
Online Access:	https://endojournals.ru/index.php/omet/article/view/9358

Similar Items

Sistema angiogeneza v norme i pri sakharnom diabete
by: Anastasia Sergeevna Severina, et al.
Published: (2004-12-01)

Profile of microRNAs associated with coronary heart disease in patients with type 2 diabetes
by: Teona A Shvangiradze, et al.
Published: (2016-12-01)

ANALYSIS OF THE LEVEL OF TRANSFORMING GROWTH FACTOR β1 IN CHILDREN WITH BRONCHIAL ASTHMA
by: Наталья Леонидовна Потапова, et al.
Published: (2019-11-01)

Forecast of development of gestational complications in women with alimentary-constitutional obesity type
by: O V Arshinova, et al.
Published: (2016-12-01)

THE INDICES DYNAMICS OF PLATELET POOL AND THE LEVEL OF TGF-Β<sub>1</sub> IN DIFFERENT FORMS OF ACUTE PANCREATITIS
by: E. N. Smolina, et al.
Published: (2018-01-01)

Prospects of therapeutic action on FGFR signaling pathway
by: M. Yu. Fedyanin, et al.
Published: (2015-06-01)

CREB3L3 transcription factor controls energy homeostasis and improves Obesity and diabetes.
by: Tatyana Sergeevna Borodich
Published: (2015-01-01)

Kardiovaskulyarnye narusheniya u detey pri sakharnom diabete
by: O A Dianov, et al.
Published: (2005-12-01)

The pathogenic basis for the development of cardiovascular disease in obesity: difficulties of diagnosis and treatment
by: Irina Ziatovna Bondarenko, et al.
Published: (2016-03-01)

Metabolicheskiy effekt gormona rostapri gipopituitarizme u vzroslykh
Published: (2010-03-01)

PREVENTIONAL SCREENING: ALL PROS AND CONTRAS
by: N. V. Pogosova, et al.
Published: (2016-06-01)

Insulin-like growth factor-1 and myocardial remodeling in female patients with arterial hypertension and metabolic syndrome
by: A. N. Zakirova, et al.
Published: (2015-11-01)

PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE
by: M. N. Mamedov, et al.
Published: (2015-12-01)

Issledovanie ONTARGET: Telmisartan ne ustupaet po effektivnosti ramiprilu u patsientov s vysokim riskom serdechno-sosudistykh oslozhneniy / sakharnym diabetom
by: Olga Konstantinovna Vikulova, et al.
Published: (2008-06-01)

An impact of overweight and obesity on the risk factors for breast cancer in postmenopausal women
Published: (2012-09-01)

Testing of hydroxyapatite nanocrystals and epidermal growth factor for healing of skin wounds in rats with an immunodeficiency
by: О Z Topolnitsky, et al.
Published: (2011-03-01)

EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS
by: E. V. Akhmedova, et al.
Published: (2015-09-01)

Pharmacoeconomical aspects of the treatment of arterial hypertension in patients with type II diabetes mellitus in outpatient department
by: J Sh Gushina, et al.
Published: (2009-03-01)

ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK
by: M. N. Kovrigina, et al.
Published: (2015-12-01)

THE INFLUENCE OF SUBCLINICAL NEPHROPATHY ON THE SUBJECTIVE HEALTH’S EVALUATION OF PATIENTS WITH MELLITUS DIABETES
by: Maria Gennad’evna Evsina, et al.
Published: (2018-03-01)

Obesity: current approaches to adequate pharmacotherapy
by: M. L. Maksimov, et al.
Published: (2016-12-01)

THE ROLE OF VASCULAR GROWTH FACTORS IN DIABETIC RETINOPATHY AND MACULAR EDEMA DEVELOPMENT
by: A. G. Iskhakova, et al.
Published: (2018-10-01)

Issledovanie ADVANCE: vliyanie Noliprela - fiksirovannoy kombinatsii ingibitora APF (Perindoprila) i diuretika (Indapamida) - na razvitie serdechno-sosudistykh oslozhneniy u patsientov s sakharnym diabetom 2 tipa
by: Marina Vladimirovna Shestakova, et al.
Published: (2008-03-01)

Метаболические эффекты миметика глюкагоноподобного пептида-1 у больных сахарным диабетом 2-го типа в сочетании с кардиоваскулярной патологией
Published: (2016-12-01)

Prediction of the risk of severe pre-eclampsia in multiple pregnancies and ways of its prevention
by: S V Barinov, et al.
Published: (2015-12-01)

Role of the fibroblast growth factor type 23 in progression of complications and imbalance of calcium-phosphoric metabolism with patients suffering chronic kidney disease
by: A. M. Yesayan, et al.
Published: (2015-03-01)

Тканеинженерная заплата, модифицированная фактором роста эндотелия сосудов, для реконструкции сосудистой стенки
by: V. V. Sevostianova, et al.
Published: (2020-12-01)

The role of matrix metalloproteinases and vascular grouth facrors in differentional diagnostic of prostate’s diseases
by: V P Avdoshin, et al.
Published: (2014-12-01)

Роль профиброгенных цитокинов в прогрессировании почечного и сердечнососудистого повреждения у детей с аутосомно-доминантной поликистозной болезнью почек
Published: (2016-03-01)

Ateroskleroz i faktory rosta (TGFbl i bFGF) u patsientovs sakharnym diabetom tipa 2
by: A N Podgrebel'nyy, et al.
Published: (2005-03-01)

Нарушение когнитивных функций потомков самцов крыс, подвергнутых стрессированию в парадигмах «стресс — рестресс» или «выученная беспомощность»: роль инсулиноподобного фактора роста 2
by: Наталья Эдуардовна Ордян, et al.
Published: (2021-05-01)

Insulin resistance in therapeutic clinic
by: Anna V. Pashentseva, et al.
Published: (2017-09-01)

Sakharnyy diabet 2 tipa, arterial'naya gipertenziya i risk serdechno-sosudistykh oslozhneniy
by: O A Kislyak, et al.
Published: (2008-03-01)

CURRENT UNDERSTANDING OF THE ROLE OF EPITHELIAL-MESENCHYMAL TRANSITION IN THE PROGRESSION OF CHRONIC KIDNEY DISEASE
by: V. E. Potapov, et al.
Published: (2016-12-01)

Body fat distribution: the answer to the apparent paradox of obesity in cardiology?
by: Daria A. Borodkina, et al.
Published: (2017-09-01)

Features of studying angiogenesis factors in patients with arterial hypertension and associated clinical conditions
by: L. A. Khaisheva, et al.
Published: (2014-08-01)

Expression Density of receptors to immunoregulatory mediators as a modulating component of biological effects of mediators on cell. Part 2
by: Sennikov Sergey Vitalievitch, et al.
Published: (2019-03-01)

The role of complement system and other inflammatory factors in the development of age-related macular degeneration
by: E A Abdulaeva
Published: (2018-08-01)

The role of glycemic control in managing type 2 diabetes
by: N. A. Chernikova
Published: (2013-12-01)

STATINS AND RISK OF INFECTIOUS DISEASES
by: O. M. Drapkina, et al.
Published: (2015-09-01)